Nasdaq: PPCB

Propanc Biopharma, Inc. (PPCB)

Propanc Biopharma, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker PPCB. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
PPCB
Exchange
Nasdaq
SEC CIK
1517681
Official filings
SEC EDGAR

Research PPCB

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Propanc Biopharma, Inc.'s stock ticker?

Propanc Biopharma, Inc. trades under the ticker symbol PPCB on Nasdaq. Its SEC Central Index Key (CIK) is 1517681.

Where can I read Propanc Biopharma, Inc.'s SEC filings?

The PPCB SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Propanc Biopharma, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze PPCB's financial statements?

The PPCB Financials page shows Propanc Biopharma, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does PPCB compare with its peers and the market?

The PPCB Peer Comparison page lines Propanc Biopharma, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.